Dae Ghon Kim

758 total citations
29 papers, 589 citations indexed

About

Dae Ghon Kim is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dae Ghon Kim has authored 29 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dae Ghon Kim's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Dae Ghon Kim is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Dae Ghon Kim collaborates with scholars based in South Korea and United States. Dae Ghon Kim's co-authors include In Hee Kim, Seong‐Hun Kim, Seung Ok Lee, Soo Teik Lee, Se‐Lim Kim, Young Il Yeom, Sang‐Wook Kim, Sang Wook Kim, Dong Wook Choi and Jong Young Choi and has published in prestigious journals such as Hepatology, FEBS Letters and Journal of Clinical Microbiology.

In The Last Decade

Dae Ghon Kim

28 papers receiving 577 citations

Peers

Dae Ghon Kim
Rocky L.K. Ho Hong Kong
Jun Qian China
Yoon Hwan Chang South Korea
Les Lang United States
Dae Ghon Kim
Citations per year, relative to Dae Ghon Kim Dae Ghon Kim (= 1×) peers Hongzhong Zhou

Countries citing papers authored by Dae Ghon Kim

Since Specialization
Citations

This map shows the geographic impact of Dae Ghon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dae Ghon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dae Ghon Kim more than expected).

Fields of papers citing papers by Dae Ghon Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dae Ghon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dae Ghon Kim. The network helps show where Dae Ghon Kim may publish in the future.

Co-authorship network of co-authors of Dae Ghon Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Dae Ghon Kim. A scholar is included among the top collaborators of Dae Ghon Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dae Ghon Kim. Dae Ghon Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Chang Hun, In Hee Kim, Seung Young Seo, et al.. (2017). 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy. World Journal of Gastroenterology. 23(2). 297–297. 1 indexed citations
2.
Lee, Chang Hun, Seung Young Seo, Seong‐Hun Kim, et al.. (2016). Cancer related gene alterations can be detected with next-generation sequencing analysis of bile in diffusely infiltrating type cholangiocarcinoma. Experimental and Molecular Pathology. 101(1). 150–156. 12 indexed citations
3.
Shin, Dong Wook, Juhee Cho, Hyung Kook Yang, et al.. (2015). Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey. Cancer Research and Treatment. 47(4). 591–599. 7 indexed citations
4.
Lee, Chang Hun, Seong‐Hun Kim, In Hee Kim, et al.. (2014). Endoscopic stenting in bile duct cancer increases liver volume. Gastrointestinal Endoscopy. 80(3). 447–455. 6 indexed citations
5.
Kim, Se‐Lim, Seong‐Hun Kim, In Hee Kim, et al.. (2014). Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer. International Journal of Molecular Medicine. 33(5). 1261–1267. 23 indexed citations
6.
Kim, In Hee, Seong‐Hun Kim, Sang Wook Kim, et al.. (2014). Clinical Features and Risk Factors for Severe Complications among Patients with Acute Hepatitis A Virus Infection in The Jeonbuk Province of Korea. Korean Journal of Gastroenterology. 63(1). 25–25. 6 indexed citations
7.
Kim, Se‐Lim, In Hee Kim, Seungok Lee, et al.. (2013). Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer. Cancer Letters. 335(2). 479–486. 38 indexed citations
8.
Kim, Kang, Seong‐Hun Kim, In Hee Kim, et al.. (2012). The successful endoscopic hemostasis factors in bleeding from advanced gastric cancer. Gastric Cancer. 16(3). 397–403. 37 indexed citations
9.
Kim, Se‐Lim, Seong‐Hun Kim, In Hee Kim, et al.. (2012). Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis. International Journal of Oncology. 41(4). 1547–1553. 34 indexed citations
10.
Hong, Sun Mi, Chang Wook Park, Hyung Jin, et al.. (2012). Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma. Clinical & Experimental Metastasis. 30(2). 177–187. 23 indexed citations
11.
Kim, Soo Mi, In‐Sun Chu, Sang Cheol Kim, et al.. (2011). Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology. 55(5). 1443–1452. 93 indexed citations
13.
Kang, Yun Hee, Chung Il Lee, Hee Gu Lee, et al.. (2010). ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids. 40(3). 1003–1013. 45 indexed citations
14.
Lee, Seung Ok, Seong‐Hun Kim, In Kim, et al.. (2009). A Case of Intrahepatic Choledochal Web That Was Diagnosed by Percutaneous Transhepatic Cholangioscopy and It Was Treated with Balloon Dilatation: Review of the Korean Cases. Clinical Endoscopy. 39(5). 319–323. 2 indexed citations
15.
Kim, Seong‐Hun, et al.. (2007). A case of combined hepatocellular-chloangiocarcinoma associated with polymyositis and chronic hepatitis B virus infection. The Korean Journal of Internal Medicine. 72(1). 79–84.
16.
Lee, Soo Teik, Seong‐Hun Kim, In Hee Kim, et al.. (2007). A superoxide anion generator, pyrogallol, inhibits the growth of HeLa cells via cell cycle arrest and apoptosis. Molecular Carcinogenesis. 47(2). 114–125. 44 indexed citations
17.
Kim, Dae Ghon, et al.. (2007). Amyloid-β-Peptide Reduces the Expression Level of Mitochondrial Cytochrome Oxidase Subunits. Neurochemical Research. 32(9). 1483–1488. 32 indexed citations
18.
Choi, Jung Kyoon, Jong Young Choi, Dae Ghon Kim, et al.. (2004). Integrative analysis of multiple gene expression profiles applied to liver cancer study. FEBS Letters. 565(1-3). 93–100. 72 indexed citations
19.
Lee, Heung Bum, et al.. (1997). Differences in Immunophenotyping of Mucosal Lymphocytes Between Ulcerative Colitis and Crohn`s Disease. The Korean Journal of Internal Medicine. 12(1). 7–15. 16 indexed citations
20.
Kim, Dae Ghon, et al.. (1989). Impaired Interleukin-2 Receptor Expression on Lymphocytes from Patients with Chronic Active Hepatitis Type B. The Korean Journal of Internal Medicine. 4(1). 34–41. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026